UK markets closed

CYduct Diagnostics, Inc. (CYDX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.3500+0.0500 (+16.67%)
At close: 02:25PM EDT

CYduct Diagnostics, Inc.

1698 Post Rd. E
Suite 1A
Westport, CT 06880
United States
888-545-9112
https://cyductdx.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees3

Key executives

NameTitlePayExercisedYear born
Mr. Dom L. GattoPresident, CEO, Secretary, Treasurer & ChairmanN/AN/A1962
Mr. Fred V. Schiemann CPACFO & DirectorN/AN/A1952
Mr. Gerald SchwebelOperations ManagerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

CYduct Diagnostics, Inc., a healthcare instrument company, develops and markets technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment, and management of disease and medical conditions. The company's products include breast endoscopy systems; 3-chip and 1-chip camera systems; cameras and accessories; endoscopic instruments, such as dissectors, graspers, scissors, needle holders, fan retractors, cautery instruments, and insufflation needles; and illumination series products, including fiber optic cables, light port adapters, light sources, and replacement lamps. It also offers insufflators; laparoscopic instruments, such as general surgery, lymphadenectomy, gynecology, and thorascopy instruments; rigid scopes and accessories, including laparoscopes, operative scopes, cystoscopes, and scope trays; trocar and cannula sets, cannulas, trocars, reducer sleeves, and seals; video carts; instrument handles that include insulated handles and non-insulated handles; and veterinary instrumentation. The company was formerly known as Solos Endoscopy, Inc. and changed its name to CYduct Diagnostics, Inc. in December 2020. CYduct Diagnostics, Inc. was founded in 1986 and is based in Westport, Connecticut.

Corporate governance

CYduct Diagnostics, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.